CALR and rheumatoid arthritis: The presence of anti-Ro/SS-A antibodies was associated with a decrease in therapeutic effects of several classes of DMARDs; that is, patients with RA that were positive for anti-Ro/SS-A antibodies and negative for anti-Ro/SS-A antibodies might represent distinct clinical subsets and may require different therapeutic strategies [27,30].